609 related articles for article (PubMed ID: 12732605)
1. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.
Hayashi M; Tsutamoto T; Wada A; Tsutsui T; Ishii C; Ohno K; Fujii M; Taniguchi A; Hamatani T; Nozato Y; Kataoka K; Morigami N; Ohnishi M; Kinoshita M; Horie M
Circulation; 2003 May; 107(20):2559-65. PubMed ID: 12732605
[TBL] [Abstract][Full Text] [Related]
2. [Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction].
Hayashi M
J Cardiol; 2004 Feb; 43(2):88-91. PubMed ID: 15046031
[TBL] [Abstract][Full Text] [Related]
3. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
4. [Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study].
Rodríguez JA; Godoy I; Castro P; Quintana JC; Chávez E; Yovanovich J; Corbalán R; Chávez A
Rev Med Chil; 1997 Jun; 125(6):643-52. PubMed ID: 9515282
[TBL] [Abstract][Full Text] [Related]
5. Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction.
Hayashi M; Tsutamoto T; Wada A; Maeda K; Mabuchi N; Tsutsui T; Matsui T; Fujii M; Matsumoto T; Yamamoto T; Horie H; Ohnishi M; Kinoshita M
J Am Coll Cardiol; 2001 Nov; 38(5):1375-82. PubMed ID: 11691511
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
[TBL] [Abstract][Full Text] [Related]
7. [Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study].
Konermann M; Odenthal HJ; Altmann C; Laschewski F; Rawert B; Trappe HJ; Sanner BM
Wien Med Wochenschr; 2000; 150(12):249-55. PubMed ID: 11008329
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group).
Savoye C; Equine O; Tricot O; Nugue O; Segrestin B; Sautière K; Elkohen M; Pretorian EM; Taghipour K; Philias A; Aumégeat V; Decoulx E; Ennezat PV; Bauters C;
Am J Cardiol; 2006 Nov; 98(9):1144-9. PubMed ID: 17056315
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction.
Uehara K; Nomura M; Ozaki Y; Fujinaga H; Ikefuji H; Kimura M; Chikamori K; Nakaya Y; Ito S
Heart Vessels; 2003 May; 18(2):67-74. PubMed ID: 12756602
[TBL] [Abstract][Full Text] [Related]
10. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
11. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
Brilla CG; Schencking M; Scheer C; Rupp H
Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
[TBL] [Abstract][Full Text] [Related]
13. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling.
Solomon SD; Anavekar NS; Greaves S; Rouleau JL; Hennekens C; Pfeffer MA;
J Am Coll Cardiol; 2004 May; 43(9):1511-4. PubMed ID: 15120803
[TBL] [Abstract][Full Text] [Related]
14. The extent of regional wall motion abnormalities identifies patients at risk of extensive left ventricular remodeling: implications for the design of post myocardial infarction trials.
Zanolla L; Marino P; Golia G; Anselmi M; Zardini P; Borghi C; Ambrosioni E
G Ital Cardiol; 1999 Jan; 29(1):20-6. PubMed ID: 9987043
[TBL] [Abstract][Full Text] [Related]
15. [Effect of spironolactone on left ventricular remodeling in patients with acute myocardial infarction].
Dong Q; Liu KS; Liu HB; Li SR; Han YP; Zhang LP; Wang Y; Liu G; Wang XP; Xu LF; Li XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):315-9. PubMed ID: 15932659
[TBL] [Abstract][Full Text] [Related]
16. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
[TBL] [Abstract][Full Text] [Related]
17. [MRT assessment of metabolic and thrombolytic therapy effects on postinfarction left ventricular remodeling].
Tarasov NI; Kokov AN; Barbarash LS
Ter Arkh; 2006; 78(9):38-43. PubMed ID: 17076223
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of left ventricular dyssynchrony after acute myocardial infarction, assessed by a tagging magnetic resonance image derived metric, as a determinant of ventricular remodeling.
Chang SA; Chang HJ; Choi SI; Chun EJ; Yoon YE; Kim HK; Kim YJ; Choi DJ; Sohn DW; Helm RH; Lardo AC
Am J Cardiol; 2009 Jul; 104(1):19-23. PubMed ID: 19576315
[TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
Ferrari R;
Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitor helps prevent late remodeling after left ventricular aneurysm repair in rats.
Nomoto T; Nishina T; Miwa S; Tsuneyoshi H; Maruyama I; Nishimura K; Komeda M
Circulation; 2002 Sep; 106(12 Suppl 1):I115-9. PubMed ID: 12354719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
